676 
Transmitted HIV Drug Resistance May Originate from Untreated and Undiagnosed Individuals: A Phylogenetic Exploration
Alison Brown*1,2, D Sudarshi3, M Fisher3, D Pao3, A Buckton1, A Johnson2, P Cane1, N Gill1, and D Pillay1,2
1Hlth Protection Agency, London, UK; 2Univ Coll London, UK; and 3Brighton and Sussex Univ Hosp, UK
Background: The extent
that men who have sex with men (MSM) with transmitted HIV drug resistance (TDR)
contributes to ongoing transmission is unknown. We explore possible sources of
recently acquired TDR through a phylogenetic and epidemiological analysis of a
large MSM open-cohort.
Methods: Between 2000 and
2006, 1144 HIV-infected MSM from a geographically contained population had
infection stage at diagnosis and a dated therapy history documented. Of these,
859 (75%) had HIV pol sequences available (obtained from plasma virus or
pro-viral DNA) from which drug resistance mutations were identified. Recent HIV
infections were defined as: anti-HIV positive test within 6 months of a
negative test; STARHS; p24 antigen+/antibody– status and
limited Western blot. Patients with drug resistance were categorised as: TDR
(recent), TDR, (non-recent) or acquired. Using incidence estimates and
epidemiological data, and through phylogenetic and conservative genetic
distance measures, the single most likely transmitter for each recently infected
TDR patient was identified. The transmitter was categorized as having acquired
resistance or TDR (recently or non-recently acquired) at the time the likely
transmission took place (dated using the estimated infection date of each
recent TDR case).
Results: Overall, of 859
MSM, 178 (20.7%) had HIV drug-resistance mutations, of which 13 (7%) had recent
TDR. The remainder had non-recent TDR (31 = 17%), acquired resistance (74 = 41%),
but for 60 cases (34%) the origin of resistance could not be categorized. Of
the 13 with recent TDR, the most likely transmitter was identified in 4 (31%)
cases, 2 of which had non-recent TDR and 2 had acquired resistance. Around the
estimated time of transmission, those untreated transmitters with TDR had viral
loads of >20,000 copies/mL and those with acquired resistance had
interrupted therapy with viral loads of >550,000 copies/mL. The most likely
transmitter could not be identified for 9 (69%) MSM (with recent TDR,
indicating a substantial proportion may have been derived from MSM with
undiagnosed infection.
Conclusions: This
exploratory analysis identifies undiagnosed infection, together with high viral
load, as risk factors for the onward transmission of resistant strains. Our
data support earlier HIV testing and initiation of ARV as public health
measures.
|